![](/img/cover-not-exists.png)
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
Barrett-Lee, Peter, Casbard, Angela, Abraham, Jacinta, Hood, Kerenza, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth, Murray, NickVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70539-4
Date:
January, 2014
File:
PDF, 497 KB
english, 2014